CRI Speaks

Let's spread the word about Immunotherapy! Click to share this page with your community.

Upcoming CRI Speaks

Currently there are no upcoming events.

Past CRI Speaks

June 21, 20199:00 AM
CRI Speaks

Immuno-Oncology: A Future Look

Hosted by the Cancer Research Institute this intimate, invitation-only event for media and health care investment analysts will explore what’s next in the IO field.

May 07, 20197:00 AM
CRI Speaks

Cancer Progress 2019

Drs. Jill O'Donnell-Tormey and Vanessa M. Lucey are participating in panel discussions at Cancer Progress.

April 11, 20198:00 AM
CRI Speaks

Kraft Precision Medicine Accelerator Workshop

Laura Peace, Consultant, Head of Clinical Alliances, Clinical Accelerator, participates in a panel discussion, 10:30 a.m.-11:15 a.m.

March 29, 201912:00 PM
CRI Speaks

2019 AACR Annual Meeting

Update on a CRI-funded pancreatic cancer trial led by Robert H. Vonderheide, M.D., D.Phil, on March 31 at 2:27 p.m.

March 03, 201912:00 PM
CRI Speaks

Inaugural Festival of Biologics San Diego

CEO Jill O’Donnell-Tormey, Ph.D., participates in the Women in Science panel on March 3, 2019 at 2:30 p.m. 

June 01, 20181:00 PM
CRI Speaks

2018 ASCO Meeting

CRI scientists present at the Annual Meeting of the American Society of Clinical Oncologists. CRI provides a daily recap of new work coming out of the conference. 

April 14, 20188:00 AM
CRI Speaks

2018 AACR Annual Meeting

CRI-funded and -affiliated scientists and clinicians showcased at the American Association of Cancer Research Annual Meeting on April 14-18, 2018, in Chicago.

April 12, 20187:15 AM
CRI Speaks

Cancer Advance Boston

On April 12, our chief medical officer, Aiman Shalabi, is a featured expert on the panel, “Immuno-Oncology: Challenges & Opportunities”.

March 19, 20187:00 AM
CRI Speaks

Fortune Brainstorm HEALTH 2018

Dr. Jill O’Donnell-Tormey, CEO and director of scientific affairs, participates in the 'Weaponizing Your Own Body' panel on Tuesday, March 20, 2018 at 7:45 am.

January 22, 20184:30 PM
CRI Speaks

Immuno-Oncology Frontiers World

Dr. Vanessa Lucey, associate director, CRI Venture Fund & Clinical Accelerator, speaks during the "Back to Basics" session on January 23, 2018 at 2:00 p.m. 

*Immunotherapy results may vary from patient to patient.